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Abstract
Background—Some humans fed a low-choline diet develop hepatosteatosis, liver and muscle
damage, and lymphocyte apoptosis. The risk of developing such organ dysfunction is increased by
the presence of single-nucleotide polymorphisms (SNPs) in genes involved in folate and choline
metabolism.
Objective—We investigated whether these changes that occur in the expression of many genes
when humans are fed a low-choline diet differ between subjects who develop organ dysfunction and
those who do not. We also investigated whether expression changes were dependent on the presence
of the SNPs of interest.
Design—Thirty-three subjects aged 20−67 y were fed for 10 d a baseline diet containing the
recommended adequate intake of choline. They then were fed a low-choline diet for up to 42 d or
until they developed organ dysfunction. Blood was collected at the end of each phase, and peripheral
lymphocytes were isolated and used for genotyping and for gene expression profiling with the use
of microarray hybridization.
Results—Feeding a low-choline diet changed the expression of 259 genes, and the profiles of
subjects who developed and those who did not develop signs of organ dysfunction differed. Group
clustering and gene ontology analyses found that the diet-induced changes in gene expression profiles
were significantly influenced by the SNPs of interest and that the gene expression phenotype of the
variant gene carriers differed significantly even with the baseline diet.
Conclusion—These findings support our hypothesis that a person's susceptibility to organ
dysfunction when fed a low-choline diet is modulated by specific SNPs in genes involved in folate
and choline metabolism.
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Choline is an essential dietary nutrient involved in a multitude of metabolic roles (1). It is a
major source of methyl groups for methionine synthesis and is needed for the structural
integrity of cell membranes, the transport of lipids from the liver, and cholinergic
neurotransmission (1). Adequate intake (AI) recommendations for choline have been
established (2), and, in population studies, diets low in choline were associated with a greater
risk of birth defects (3,4) and with high homocysteine concentrations in blood (5). We
previously reported that some humans fed a diet low in choline developed hepatosteatosis,
experienced liver and muscle damage, and had greater lymphocyte apoptosis (6–10). All of
these changes were reversed after a period of choline repletion. The susceptibility to these
outcomes was not the same in all subjects; it varied with the presence of single-nucleotide
polymorphisms (SNPs) within the genes involved in folate and choline metabolism (7,8). With
the notable exception of the carriers of the choline dehydrogenase (CHDH) variant allele (318
A→C; rs9001), who were protected against developing organ dysfunction (8), carriers of the
methylenetetrahydrofolate dehydrogenase (MTHFD1) synthase variant (1958 G→A;
rs2236225), the CHDH variant (432 G→T; rs12676), and the phosphatidylethanolamine
methyltransferase (PEMT) variant (−744 G→C; rs12325817) alleles were at greater risk of
developing organ dysfunction when fed a low-choline diet than were the carriers of the
corresponding wild-type alleles (7,8).
In this study, we fed humans a diet containing recommended amounts of choline, then fed the
same subjects diets low in choline content, and then assessed gene expression in lymphocytes
at the end of each feeding period. We determined whether ingesting a low-choline diet was
associated with changes in gene expression, whether those subjects who developed organ
dysfunction differed in gene expression from those who did not, and whether changes in gene
expression were related to the presence of SNPs.
SUBJECTS AND METHODS
Subjects
Healthy men (n = 31) and women (n = 35) were recruited for the study. Inclusion was contingent
on an age-typical good state of health as determined by physical examination and standard
clinical laboratory tests, such as complete blood count, blood chemistries, and fasting lipids
and liver function tests and on the absence of known chronic diseases. Twenty-two subjects
admitted to the study had minor elevations in blood lipids that were not deemed of clinical
significance by the study physician. Of the originally recruited 66 subjects, 61 completed at
least the initial and depletion phases. Of those 61 subjects, 1 was excluded because of a 9-kg
weight loss during the study, 3 were excluded because they did not comply with diet
restrictions, and 6 were excluded because they did not have baseline measurements; thus, 51
subjects were included in analyses. Of those subjects, 18 were excluded from the gene array
analyses (see Microarray data analysis). The remaining 14 men and 19 women ranged in age
from 20 to 67 y and had a body mass index (BMI; in kg/m2) between 19 and 31, which they
maintained throughout the study. The ethnic distribution of these participants was 61% white,
30 African American, and 9% Asian, which reflects the local population characteristics of the
Raleigh-Durham-Chapel Hill area.
Written informed consent was obtained from all participants. The study protocol was approved
by the Institutional Review Board at the University of North Carolina at Chapel Hill (UNC-
CH).
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The participants were admitted to the UNC-CH General Clinical Research Center, where they
remained under the supervision of study staff for the duration of the study. Research diets
administered to the subjects, which were composed of 0.8 g high-biologic-value protein/kg
body wt, with 30% of energy from fat and 70% of energy from carbohydrate, were prepared
in-house to protocol specifications and have been described in detail elsewhere (11). Total food
intake was adjusted to be isocaloric and to provide adequate intakes of macronutrients and
micronutrients. Initially, all participants received a diet of commonly eaten foods containing
550 mg choline · 70 kg body wt−1 · d−1—the presumed AI (2)—and 400 dietary folate
equivalents (DFE)/d. The dietary choline content was confirmed as described previously
(11), and the folate content was calculated by using the US Department of Agriculture SR16
database and PRONUTRA software (version 3.1.0.13; Viocare, Princeton, NJ). After 10 d of
this baseline diet, liver fat was measured, and 48 mL blood was collected by venipuncture and
processed for peripheral lymphocytes as described below. The subjects were randomly
assigned to 2 groups—diet folate only or diet folate supplemented with 400 μg folic acid/d—
and then were fed a diet in which the choline content was reduced to <50 mg/d, as confirmed
by analysis of duplicate food portions. For the rest of the study, all diets offered to the diet-
folate-only group contained 100 DFE/d, whereas the folic acid–supplemented group received
an additional 668 DFE/d. Periodic measurements of urinary choline and betaine concentrations
(12) were used to confirm compliance with the dietary restrictions. Subjects followed this
depletion diet until they developed organ dysfunction associated with choline deficiency or for
42 d if they did not develop organ dysfunction. Blood (48 mL) was again collected at the end
of the depletion phase. Humans were deemed to have organ dysfunction associated with choline
deficiency if they had a >5-fold increase in serum creatine phosphokinase (CPK) activity
(measurements were taken every 3−4 d) or if they had a >28% increase in liver fat content
while following the choline-depletion diet (measurements were taken on days 21 and 42 of the
choline-depletion diet) and if this increase in CPK activity or liver fat content was resolved
when choline was returned to the diet. The change from baseline in liver fat content was
estimated by using magnetic resonance imaging (MRI) in a clinical magnetic resonance system
(Vision 41.5T; Siemens Medical Solutions, Malvern, PA) with a modified “In and Out of
Phase” procedure that was described previously (13). Fat content was derived from
measurements across 3−5 liver slices per subject and standardized to similarly measured slices
of spleen.
Isolation of lymphocyte RNA and quality assessment
At the end of the baseline and choline-depletion diet phases, peripheral lymphocytes were
isolated from blood within 2 h of collection by using Ficoll-Hypaque gradient in evacuated
tubes with sodium citrate (Vacuatainer CPT tubes; Becton Dickinson, Franklin Lakes, NJ),
and suspended in TRIzol Reagent (Invitrogen, Carlsbad, CA). Total RNA was isolated
according to the manufacturer's protocol, purified with the use of an RNeasy kit (Qiagen,
Valencia, CA), and diluted to a standard concentration of 100 μg/mL. The subsequent
procedures were performed at the UNC-CH Genomics Core Facility. Each sample (0.5 μg),
including the reference RNA, was first tested on an Agilent 2100 Bioanalyzer (Agilent
Technologies, Palo Alto, CA) to ensure high-quality RNA before being diluted for
hybridization.
Genotyping
Genomic DNA was prepared from peripheral blood with a commercial extraction kit
(PureGene; Gentra Systems, Minneapolis, MN) according to the manufacturer's instructions
and diluted to a standard concentration of 1 μg/mL. The cytoplasmic MTHFD synthase
(MTHFD1-G1958A) was amplified by multiplex polymerase chain reaction (PCR), purified,
Niculescu et al. Page 3













and then analyzed with matrix-assisted laser desorption ionization time-of-flight mass
spectrometry (7,14). For the PEMT and CHDH genes, DNA sequencing was performed on
double-stranded DNA templates obtained from genomic DNA by using PCR amplification
(8).
Microarray hybridization and data retrieval
We mixed 12 μg of sample and an equal amount of universal human reference RNA
(Stratagene, La Jolla, CA) with anchored oligo-dT Primer mixture, and amplified the mixture
by using a thermal cycler (70 °C for 5 min to anneal; 42 °C for 1.5 h). The cDNA was then
labeled in a reverse transcriptase reaction with dUTP CyDye–labeled nucleotides (Cy3 for
reference and Cy5 for experiment) by using a CyScribe First-Strand cDNA Labeling Kit [GE
Healthcare (formerly Amersham Biosciences), Piscataway, NJ]. The labeled cDNA was then
purified by degrading the mRNA with NaOH at 37 °C for 15 min and washing the samples
with Tris-EDTA buffer by using a Microcon PCR filter (Millipore, Bedford, MA). The
combined Cy3+Cy5 sample was then applied to a glass slide array, sealed in a hybridization
chamber, and incubated in a 65 °C water bath overnight. The human oligo-arrays with 16 000
spots were produced at the Genomics Core Facility in the same batch by using 60-mer
oligonucleotides (Compugen USA, Jamesburg, NJ). After hybridization, the array slides were
washed and spun dry before being scanned to collect the fluorescent images (GenePix 4000B
fluorescent scanner; Axon Instruments, Union City, CA). Images were gridded, and data were
collected with the use of GENEPIX PRO microarray acquisition and analysis software (version
5.0; Axon Instruments). Detailed protocols are available at
http://cancer.med.unc.edu/genomicscore/. Images obtained were analyzed by superimposing
a grid for each array with the use of the GENEPIX PRO software. All spots of poor quality (as
determined by visual inspection) were flagged as bad and removed from further analysis.
Microarray data analysis
All of the collected raw data files were further processed by uploading them into the UNC
Microarray Database (https://genome.unc.edu/), and the data were filtered and retrieved
according to the following criteria: 1) data were retrieved by the immutable Stanford University
Identification (SUID) reference number to average the replicate spots by gene name and present
the result as one (ie, to collapse them); 2) spots were selected only if they had both Channel 1
and Channel 2 Lowess-normalized means ≥30% above background; and 3) genes were selected
only if they had >70% good data. No cutoffs were selected. Final data were expressed as log
(base 2) of lymphocyte RNA-reference RNA Lowess normalized ratio (mean). The final
number of arrays (and hence the number of subjects included in further analyses) was
influenced by various criteria: not all RNA samples were of good quality, some blood samples
did not contain enough RNA, and not all arrays passed the quality test. Therefore, of the 51
subjects initially included in the study, only 33 had arrays that were suitable for analysis. Of
these 33, not all had 2 arrays (1 for baseline and 1 for depletion), so the number of arrays
available at baseline was 30, and the number of arrays available at depletion was 25 (Table 1).
Statistical analysis of gene expression
Subjects were grouped for 12 comparisons (Table 1) according to the following criteria:
presence or absence of organ dysfunction when fed a low-choline diet (hepatosteatosis and
liver and muscle damage); timepoint (end of the baseline phase or end of the depletion phase);
and the presence of a specific SNP for PEMT, MTHFD, and CHDH. Significance analysis of
microar-rays (SAM) (15) was applied to the final data by using TIGR MEV software [version
3; Dana-Farber Cancer Institute, Boston, MA (16)]. We used the one-class response type and
100 permutations or the maximum allowed permutations (if <100) to select the genes that are
significantly changed across each of the groups. An arbitrary false discovery rate (FDR) of
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maximum 5% was chosen, and the closest threshold value (delta, or Δ) was selected for each
group. The FDR is the expected percentage of false predictions; therefore, at 5% FDR, 95%
of the observations are reproducible and not due to chance. The software generated a list of
significantly overexpressed and underexpressed genes (d score assessment), and the q value
(the lowest FDR at which the gene is called significant) was computed for each gene. The data
generated by the use of SAM were converted accordingly for subsequent gene ontology (GO)
classification: −1 for underexpression, 0 for no change, and 1 for overexpression. The defined
groups (Table 1) were clustered according to their changes in gene expression (16). Each group
was considered as an experiment, and gene changes were expressed as an average of all the
arrays within the group.
Cluster analysis
The TIGR MEV software was used for cluster analysis, in which groups defined in Table 1
were clustered according to changes in gene expression (post-SAM analysis). Hierarchical
clustering was assessed by using the average Euclidean distance between groups.
Gene ontology classification
GOMINER software (version 1.22; Georgia Tech University, Atlanta, GA; Internet:
http://discover.nci.nih.gov/gominer/) was used to construct a GO list of the significantly
changed genes (17), by using gene symbols as identifiers. Data from the SAM output file were
converted to text files and GOMINER generated a list of genes classified by their various GO
classes, according to the default database (com.mysql.jdbc.Driver at
jdbc:mysql://discover.nci.nih.gov/GEEVS). Fisher's exact tests were performed to determine
the significance of changes within the total number of genes in each GO class, and significance
was separately assessed for the number of genes that were overexpressed, underexpressed, or
both (P < 0.05).
Gene expression validation
A small subset of genes was selected to determine the validity of the array-generated data. Real
time reverse transcriptase (RT)–PCR was used to assess the expression of 4 of the most
overexpressed genes and 4 of the most underexpressed genes. Primers for these 8 genes—
FOXA1, PRAME, TERT, CDCA8, CHEK1, IL2RB, TNFAIP3, and NFKBIA—were purchased
from SuperArray (Frederick, MD) as was 18S rRNA, which was used as the normalization
gene. Equal amounts of RNA were pooled from all subjects at baseline and depletion,
respectively. For all genes but one, 100 ng pooled template RNA was used in quintuplicate
reactions (one-step RT-PCR) in a QuantiTect SYBR Green RT-PCR kit (Qiagen); for 18S
RNA, 10 pg template RNA was used. All reactions were performed on an iQ5 Real-Time PCR
Detection System (Bio-Rad Laboratories, Hercules, CA) under the following cycling
conditions: reverse transcription for 30 min at 50 °C; initial activation for 15 min at 95 °C; and
45 cycles of denaturation for 15 s at 94 °C, annealing for 30 s at 55 °C, and extension for 30 s
at 72 °C, which were followed by data acquisition for the melting curves. The differences and
statistical assessment in gene expression were computed by using the comparative threshold
(ΔΔCT) method with the REST384 add-in for EXCEL (Internet:
http://www.gene-quantification.de/) (18), and gene expression changes were expressed as 18S-
normalized ratios between depletion and baseline. Statistical significance of change was
assessed by using both the Student t test and the nonparametric pairwise fixed reallocation
randomization test provided by REST (18).
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Regulation of gene expression by DNA methylation
We used the DNA Methylation Database (Internet: http://www.methdb.de/; last accessed
12/05/2006) to compare genes found to be changed by dietary choline with those reported to
have their expression regulated by DNA methylation (19).
RESULTS
Changes in gene expression between baseline and depletion
Of the 12 034 unigenes present within the arrays, 152 were underexpressed, and 107 were
overexpressed in subjects after the low-choline diet phase of the study. A list of selected genes
(the 20 most overexpressed and the 20 most underexpressed genes) is shown in Table 2. When
subjects were further subclassified according to the absence or presence of signs of organ
dysfunction (fatty liver, increased plasma CPK, or both) after being fed a low-choline diet, the
gene expression profiles of the 2 groups could be differentiated (Table 2). From the ALL
SUBJECTS group, we chose a limited number of genes to validate the array data by real-time
RT-PCR (Table 3). With the exception of CHEK1, changes in gene expression, given as the
relative ratio between depletion and baseline, were confirmed as significant by one or both of
the statistical tests (t test and the pairwise fixed reallocation randomization test).
Hierarchical clustering between defined groups
Using the data obtained from SAM analysis, we clustered the groups defined in Table 1 to
determine whether specific changes in gene expression profiles were associated with the
presence of signs of organ dysfunction when subjects were following a low-choline diet, with
the presence of PEMT, CHDH, and MTHFD1 SNPs, or both. In addition, we investigated
whether gene expression profiles at baseline were different between these groups (which would
suggest a different phenotype at baseline). The tree node of the groups, each one being
considered an experiment, is shown in Figure 1. According to the node distribution, 2 main
branches were generated for all the experiments. One branch included the PEMT and
MTHFD1 groups surrounding the group with all subjects at the end of the depletion phase
[ALL(D)]. The other main branch includes both CHDH polymorphisms, and the groups based
on the presence (SIGNS) or the absence (NO SIGNS) of signs of organ dysfunction, all centered
around the main ALL SUBJECTS group. The ALL SUBJECTS, SIGNS, and NO SIGNS
groups were used to compare gene expression at the end of the depletion phase and the end of
the baseline phase. ALL(D) compared the SIGNS group with the NO SIGNS group at the end
of the depletion period. Four clusters were identified with the smallest distance: 1) subjects
with the PEMT SNP fed a low-choline diet [PEMT(D)] associated with women with the PEMT
SNP fed a low-choline diet [PEMT(W)]; 2) ALL(D) associated with subjects with the
MTHFD1 SNP fed a low-choline diet [MTHFD1(D)]; 3) ALL SUBJECTS associated with
subjects who developed organ dysfunction when fed a low-choline diet (SIGNS); and 4) one
of the CHDH SNPs [CHDH(G→T)] associated with the FOLATE group.
Changes in gene expression across all groups
When the SAM analysis was performed for all groups defined in Table 1, changes for 1054
unigenes were significant. A complete list of these genes is available at
http://www.unc.edu/zeisel_lab/. On the basis of our GO analysis, we present data for a limited
number of genes (Figure 2) that are included in the following GO classes of special interest
for our human study: folate-thymidine metabolism (GO 19860, 42083, and 46104), apoptosis
(GO 6915, 6916, 6917, 8632, 30693, 43027, 43065, and 43154), DNA damage-repair (GO 77,
724, 725, 31570, 42770, and 51908), cell cycle regulation-proliferation (GO 4861 and 8283),
immune-inflammatory response and lymphocyte differentiation-activation (GO 1772, 6952,
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6954, 6955, 19731, 19732, 19864, 30098, 42113, 42742, and 50832), epigenetic regulation
(GO 8327, 35035, and 45815), and telomere maintenance (GO 3720, 3721, 5697, and 42162).
Gene ontology analysis
GO analysis was performed for all genes deemed significantly changed within any of the groups
defined in Table 1. Fisher's exact test indicated either unidirectional (up or down) or
bidirectional (both up and down) changes for 1216 GO classes (a complete list of changes
within GO classes is available at http://www.unc.edu/zeisel_lab/). Changes across selected GO
classes listed above are shown in Table 4, where the vast majority of changes are in one
direction, which suggests that, within each GO class, changes in gene expression are
functionally convergent.
Genes regulated by DNA methylation
Previous reports in cell culture and animal model systems show that dietary choline modulates
gene expression by altering DNA methylation (20,21), but no data are yet available in humans
fed a low choline diet. Using the only available public database on DNA methylation (see
Subjects and Methods), we identified 13 of the 1024 genes changed in our study that were
reported to be regulated by DNA methylation in various studies using human tissues or human
cells in culture (Table 5).
DISCUSSION
We found that a low-choline diet induced changes in lymphocyte gene expression in humans.
These changes included (but were not limited to) changes in expression of genes functionally
involved in folate metabolism, apoptosis, DNA damage-repair, cell cycle regulation, immune
response, epigenetic regulation, and telomere maintenance, which suggested that dietary
choline deficiency can alter the functionality of many pathways. Subjects who developed organ
dysfunction while following a low-choline diet differed from those who did not develop organ
dysfunction in their expression of many genes, including some of those related to any or all of
apoptosis, the DNA integrity checkpoint, and genes of cell cycle regulation. Subjects with the
PEMT (rs12325817) and MTHFD1 (rs2236225) SNPs, previously shown to predispose a
person to developing organ dysfunction when fed a low-choline diet (7,8), differed at baseline
from those subjects without the SNP in their expression of apoptosis, the DNA damage
checkpoint, and cell proliferation control genes, which suggests that they are phenotypically
different even before a low-choline diet is administered.
In different comparison groups, choline deficiency induced different patterns of change (Figure
1). Moreover, many of the results reported within all subjects (baseline compared with
depletion, ALL SUBJECTS) could be misleading because these changes were not homogenous
when subjects were classified on the basis of signs of organ dysfunction (Table 2 and Figure
2). For instance, 3 of the genes with the largest change in expression (CHEK1, GBE1, and
KIF20A) were differently expressed in the NO SIGNS group than in the SIGNS group (Table
2). CHEK1 is involved in DNA repair in human T lymphocytes (22). GBE1 is required for
sufficient glycogen accumulation and is normally underexpressed in whole human blood (23).
KIF20A regulates the transport of Golgi membranes and associated vesicles along microtubules
(24).
By clustering the groups according to genotype (Figure 1), we found that different patterns in
gene expression do indeed support this classification. For example, the previously reported
(8) protective CHDH (318 A→C) genotype grouped close to the NO SIGNS group—those
who had no clinical symptoms while following the low-choline diet—whereas the CHDH (432
G→T) genotype, which was reported to increase susceptibility to choline deficiency (8),
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grouped with the SIGNS group. Moreover, the NO SIGNS and SIGNS groups were intercalated
by the ALL SUBJECTS group, which supports the heterogeneity of the previously reported
responses to dietary choline deficiency. Included in the other arm from the clustering analysis
were the PEMT and MTHFD1 genotypes, which grouped around the ALL(D) group. This
cluster supported our hypothesis that genetic differences account for the presence or absence
of organ dysfunction in humans depleted of choline (7,8). This analysis also found that the
presence of the PEMT and MTHFD1 genotypes could confer differences in the phenotypes at
baseline, which suggests that different persons may have different susceptibility to dietary
choline deficiency and that the risk of choline deficiency is greater in women who are carriers
of the PEMT allele [this group was closer to the ALL(D) group than to the PEMT(D) group].
Harder to interpret is the unexpected clustering of the FOLATE group (those receiving folate
supplements versus those who did not) close to the CHDH (432 G→T) genotype.
To construct a better picture of the potential functional significance of these gene expression
patterns, we used GO analysis to group genes according to their functional roles. The
heterogeneity of the response to a low choline diet was also shown at this level of analysis.
Genes involved in folate metabolism were most affected in the carriers of the MTHFD1 and
CHDH (432 G→T) alleles (Table 4). A different pattern was observed for genes involved in
apoptosis (Table 4), in which the MTHFD1 polymorphic allele carriers were the most affected
(increases in apoptosis, induction of apoptosis, caspase activity, positive regulation of
apoptosis, and decreased expression of genes involved in negative regulation of caspase
activity). This result is consistent with our previous data, which showed that humans who
developed organ dysfunction when fed a choline-deficient diet were more likely to have the
MTHFD1 variant allele (7) and to have increased lymphocyte DNA damage and apoptosis, as
measured by caspase activity, than were those who did not develop organ dysfunction (9). It
is interesting that the same trends were present in these subjects at baseline, which suggests
that their higher susceptibility to choline deficiency may be due to effects present even when
subjects are consuming a normal diet. For carriers of the PEMT polymorphic allele, the most
affected genes were grouped within GO classes involved in telomere maintenance; notably,
these alterations were more extensive in female PEMT allele carriers. Telomeres are the
protein-DNA structures that protect chromosome ends from being recognized as double-
stranded DNA breaks, and their maintenance is important for cell longevity, normal cell
cycling, and prevention of cancer (25).
Our findings suggest that dietary choline deficiency may affect the homeostatic mechanisms
responsible for telomere maintenance, perhaps by epigenetic changes in gene expression. The
folate status of subjects had little effect on the gene expression changes seen in GO analyses.
Some genes that are regulated by DNA methylation were also identified as being changed by
a low-choline diet (Table 5). In cultured human neuroblastoma cells and in rodent models, cho-
line deficiency alters both global and gene-specific DNA methylation and the expression of
these genes (20,21). Therefore, we suggest that the observed choline deficiency–induced
changes in gene expression occurred because of altered methylation in promoter regions of the
genes involved. Among the genes changed in choline deficiency that are known to be regulated
by gene methylation, the insulin-like growth factor 2 (IGF2) is an imprinted gene; loss of
imprinting is associated with cancer in various experimental models (as reviewed in reference
26). Another gene identified as being changed by dietary choline and known to be regulated
by methylation is telomerase reverse transcriptase (TERT), the product of which is the protein
component of a ribonucleoprotein polymerase that maintains telomere ends by addition of the
telomere repeat TTAGGG, and its deregulation is involved in both cellular senescence
(telomere shortening) and carcinogenesis in leukemic cells (27).
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In conclusion, dietary choline deficiency induced changes in gene expression profiles in human
lymphocytes, and these patterns correlated with the occurrence of organ dysfunction and
apoptosis in humans fed a low-choline diet. These outcomes also correlated with
polymorphisms in genes that regulate folate and choline metabolism. Further studies are
required to determine whether these changes are regulated by epigenetic mechanisms and to
identify other populations at risk for dietary choline deficiency.
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Cluster analysis. All comparison groups defined in Table 1 were subjected to cluster analysis
(see Materials and Methods) to determine the distance of change between groups, as defined
by the node structure indicated. ALL SUBJECTS, comparison of all subjects (the end of the
depletion phase compared with the end of the baseline phase); SIGNS, the subjects who
developed organ dysfunction when fed the low-choline diet; NO SIGNS, the subjects who did
not develop organ dysfunction (comparing the end of the depletion phase with the end of the
baseline phase). For each polymorphism, the gene symbol is indicated. The choline
dehydrogenase single-nucleotide polymorphisms are indicated by the nucleotide replacement,
and the sample is at the end of depletion phase. The notation “(B)” after the gene symbol
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indicates the sample after the baseline (adequate choline) phase; “(D)” after the gene symbol
indicates the sample after the low-choline diet phase; “(W)” after the gene symbol indicates
women only after the depletion phase. FOLATE compares subjects with and without folate
supplementation at the end of the depletion phase. The number of arrays for each comparison
is provided in Table 1. Red indicates overexpression, green indicates underexpression, and
black indicates no change in gene expression.
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Gene expression profiles across all groups. The computed change in expression is shown for
each gene included in gene ontology (GO) classes pertaining to folate-thymidine metabolism,
apoptosis, DNA damage-repair, cell cycle regulation-proliferation, immune-inflammatory
response and lymphocyte differentiation-activation, epigenetic regulation, and telomere
maintenance. ■, overexpression; , no change; □, underexpression within each comparison
group (by significance analysis by microarray; the false discovery rate was <5%) as indicated
in Table 1. ALL SUBJECTS, comparison of all subjects (the end of the depletion phrase
compared with the end of the baseline phase); SIGNS, the subjects who developed organ
dysfunction when fed the low-choline diet; NO SIGNS, the subjects who did not develop organ
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dysfunction (comparing the end of the depletion phase with the end of the baseline phase). For
each polymorphism, the gene symbol is indicated. The choline dehydrogenase single-
nucleotide polymorphisms are indicated by the nucleotide replacement, and the sample is at
the end of depletion phase. The notation “(B)” after the gene symbol indicates the sample after
the baseline (adequate choline) phase; “(D)” after the gene symbol indicates the sample after
the low-choline diet phase; “(W)” after the gene symbol indicates women only after the
depletion phase. FOLATE compares subjects with and without folate supplementation at the
end of the depletion phase. The number of arrays for each comparison is provided in Table 1.
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Table 2
Selected genes with expression changes between baseline and depletion1
d Score









ALDH1A2 Aldehyde dehydrogenase 1 family, member A2 3.9 4.0 3.6
ARHGAP9 Rho GTPase—activating protein 9 −5.0 −4.5 =2
BUB1B Budding uninhibited by benzimidazoles 1 homolog β 4.7 = 4.9
CCL2 Chemokine (C-C motif) ligand 2 4.0 = 3.9
CD163 CD163 molecule −4.0 = =
CD36 CD36 molecule (thrombospondin receptor) −7.3 −8.5 =
CDCA8 Cell division cycle—associated 8 4.1 4.2 3.9
CHEK1 CHK1 checkpoint homolog −5.0 −7.2 3.1
COLEC12 Collectin subfamily member 12 4.7 4.6 4.6
CST3 Cystatin C (amyloid angiopathy and cerebral hemorrhage) −4.2 −3.7 =
CTSL Cathepsin L 4.0 4.7 =
CX3CR1 Chemokine (C-X3-C motif) receptor 1 −8.5 −7.9 =
DOCK2 Dedicator of cytokinesis 2 −4.1 −4.2 =
FOXA1 Forkhead box A1 6.0 7.3 4.9
GBE1 Glucan (1,4-α), branching enzyme 1 4.2 −1.4 4.0
GZMK Granzyme K (granzyme 3; tryptase II) −4.5 = =
HSPA5 Heat shock 70-kDa protein 5 (glucose-regulated protein,
78 kDa)
4.0 4.9 =
HSPCB Heat shock protein 90-kDa α (cytosolic), class B member
1
−4.4 = −3.8
IL2RB Interleukin 2 receptor β −8.2 −7.8 =
KIF20A Kinesin family member 20A 5.4 −1.1 4.2
KIF23 Kinesin family member 23 3.9 4.8 3.5
KLRF1 Killer cell lectin—like receptor subfamily F, member 1 −4.3 = −3.8
MAL2 Mal, T cell differentiation protein 2 5.8 6.1 5.4
MARCH1 Membrane-associated ring finger (C3HC4) 1 −4.3 = −3.8
MGP Matrix Gla protein 6.4 6.5 =
MMP2 Matrix metallopeptidase 2 4.7 4.8 =
MYOM2 Myomesin (M protein) 2, 165 kDa −4.0 = −4.0
NFKBIA Nuclear factor of kappa light polypeptide gene enhancer
in B cell inhibitor α
−4.1 = =
PDAP1 PDGFA-associated protein 1 −4.4 = =
PLAUR Plasminogen activator, urokinase receptor −4.3 = =
PRAME Preferentially expressed antigen in melanoma 5.9 6.9 =
PTPRCAP Protein tyrosine phosphatase, receptor type, C-associated
protein
4.4 = 4.5
RGS19 Regulator of G protein signaling 19 −4.6 −4.1 =
RNPEPL1 Arginyl aminopeptidase (aminopeptidase B)—like 1 −4.5 −3.7 =
SFRP1 Secreted frizzled-related protein 1 5.1 5.8 4.5
SLC7A7 Solute carrier family 7 (cationic amino acid transporter, y
+ system), member 7
−5.9 −5.6 −5.8
SMARCA1 SWI/SNF-related, matrix-associated, actin-dependent
regulator of chromatin, subfamily a, member 1
5.9 = 4.5
TERT Telomerase reverse transcriptase 4.7 3.8 5.3
TNFAIP3 Tumor necrosis factor-α—induced protein 3 −4.3 = =
UCK1 Uridine-cytidine kinase 1 5.1 = 5.6
1
Listed are the 20 most overexpressed and the 20 most underexpressed genes. Changes in the genes are presented as d scores. All d scores were calculated
by using a delta value corresponding to a maximum false discovery rate of 5% for each comparison group. A positive d score indicates overexpression,
and a negative d score indicates underexpression. ALL SUBJECTS, comparison of all subjects (depletion phase versus end of baseline); SIGNS, subjects
who developed organ dysfunction when fed the low-choline diet; NO SIGNS, subjects who did not develop organ dysfunction (end of the depletion phase
versus end of baseline).
2
No change according to significance analysis of microarrays (all such).
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